BAY 1251152

• Description:

  BAY 1251152 is the first potent, selective, orally available PTEFb/CDK9 inhibitor with biochemical IC50 of 9 nM and MOLM13 cell IC50 of 29 nM.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  404.436

• Molecular Formula:

  C19H18F2N4O2S

• Notes:

  Research use only, not for human use.

• Receptor:

  CDK

• CAS Number:

  1610358-56-9